[Skip to Content]
[Skip to Content Landing]

Diagnosing the Cause of Dementia: Why Is This Important?

Learning Objectives
1. Identify and explain the benefits of early detection and diagnosis of mild cognitive impairment and/or dementia
2. Recognize that Alzheimer's disease can be accurately diagnosed prior to autopsy through further, iterative testing after a failed cognitive assessment
0.25 Credit CME

This activity is intended to meet the educational needs of primary care clinicians who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.

Please finish the activity before taking the quiz.
Close

Sign in to take quiz and track your certificates

Provider Education from the Alzheimer's Association®
Understand how to confidently approach the detection, diagnostic and care-planning process for your patients with cognitive impairment and dementia. Learn more

Activity Information

Credit Designation Statement: The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society. Nurse practitioners and physician assistants may receive a maximum of 0.25 Category 1 credits for completing this activity.

Financial Disclosure Statement: ACHL requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.

The following financial relationships have been provided:

Eric McDade, D.O., has no relevant financial relationships to disclose.

David B. Carr, M.D., has no relevant financial relationships to disclose.

Lenise Cummings-Vaughn, M.D., has no relevant financial relationships to disclose.

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

Authors:

David B. Carr, M.D.

Eric McDade, D.O.

Lenise Cummings-Vaughn, M.D.

References:
1.
Alzheimer's Association, Medical and Scientific Advisory Council.  Behavioral symptoms. 2016. Accessed August 2016. http://www.alz.org/professionals_and_researchers_behavioral_symptoms_pr.asp
2.
NIH. NIA.  Health & Aging. Forgetfulness: knowing when to ask for help.  Accessed August, 2016. https://www.nia.nih.gov/health/publication/forgetfulness
3.
McKhann  GM, Knopman  DS, Chertkow  H,  et al.  The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute of Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.  Alzheimer's & Dement. 2011;7:263–269.Google Scholar
4.
Alzheimer's Disease International.  World Alzheimer Report 2016. https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf. Accessed October 2016.
5.
Bradford  A, Kunik  ME, Schulz  P, Williams  SP, Singh  H.  Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors.  Alzheimer Dis Assoc Disord. 2009;23(4):306–14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787842/Google Scholar
6.
Cordell  CB, Borson  S, Boustani  M,  et al.  Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting.  Alzheimer's Dement. 2013;9(2):141–50.Google Scholar
7.
Kotagal  V, Langa  KM, Plassman  BL,  et al.  Factors associated with cognitive evaluations in the United States.  Neurology. 2015;84(1):64–71.Google Scholar
8.
Plassman  BL, Langa  KM, Fisher  GG,  et al.  Prevalence of dementia in the United States: the Aging, Demographics, and Memory study.  Neuroepidemiology. 2007;29(1-2):125–32.Google Scholar
9.
Carter  RE, Rose  DA, Palesch  YY,  et al.  Alzheimer's disease in the family practice setting: assessment of a screening tool.  Prim Care Companion J Clin Psychiatry. 2004;6(6):234–238.Google Scholar
10.
Jobst  KA, Barnetson  LP, Shepstone  BJ.  Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-IIIR criteria, SPECT, Xray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.  Int Psychogeriatr. 1998;10(3):271–302.Google Scholar
11.
Mok  W, Chow  TW, Zheng  L,  et al.  Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians.  Am J Alzheimer's Dis Other Demen. 2004;19(3):161–165.Google Scholar
12.
Kazee  AM, Eskin  TA, Lapham  LW,  et al.  Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria.  Alzheimer's Dis Assoc Disord. 1993;7(3):152–64.Google Scholar
13.
Alzheimer's Association. 2015.  Alzheimer's disease facts and figures.  Alzheimer's & Dementia. 2015;11(3):332–384.Google Scholar
14.
Blendon  RJ, Benson  JM, Wikler  EM,  et al.  The impact of experience with a family member with Alzheimer's disease on views about the disease across five countries.  Int J Alzheimer's Dis. 2012;2012:903645.Google Scholar
15.
Carpenter  BD, Xiong  C, Porensky  EK,  et al.  Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment.  J Am Geriatr Soc. 2008;56(3):405–412.Google Scholar
16.
Grossberg  GT, Christensen  DD, Griffith  PA,  et al.  The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: recommendations of an expert consensus panel.  Prim Care Companion J Clin Psychiatry. 2010;12(1): doi: 10.4088/PCC.09cs00833oliGoogle Scholar
17.
Dubois  B, Padovani  A, Schltens  P, Rossi  A, Dell'Agnello  G.  Timely diagnosis for Alzheimer's disease: a literature review on benefits and challenges.  J Alzheimer's Dis. 2015;49(3):617–631. PMC4927869. Accessed October 2016. https://www.ncbi.nlm.nih.gov/pmc/articles/Google Scholar
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
Close